4.
Chu R. (2009) Biogenerics or Biosimilars? Discussing the Present, Considering the Future. Stockholm Network. Dorvignit D., Palacios J.L., Merino M., Hernández T., Sosa K.,
Casaco A., López-Requena A., Mateo de Acosta C. (2012) Expression and biological characterization of an antiCD20 biosimilar candidate antibody: A case study. Mabs 4(4): 488-496.